Compare POWI & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POWI | HTFL |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 1997 | N/A |
| Metric | POWI | HTFL |
|---|---|---|
| Price | $48.96 | $24.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $61.00 | $38.20 |
| AVG Volume (30 Days) | 881.0K | ★ 1.4M |
| Earning Date | 05-11-2026 | 03-18-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $443,504,000.00 | N/A |
| Revenue This Year | $8.12 | $23.36 |
| Revenue Next Year | $16.54 | $23.03 |
| P/E Ratio | $128.49 | ★ N/A |
| Revenue Growth | ★ 5.86 | N/A |
| 52 Week Low | $30.86 | $20.13 |
| 52 Week High | $60.12 | $41.22 |
| Indicator | POWI | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 50.13 |
| Support Level | $44.24 | $20.27 |
| Resistance Level | $51.00 | $25.05 |
| Average True Range (ATR) | 1.84 | 1.82 |
| MACD | 0.28 | 0.53 |
| Stochastic Oscillator | 64.74 | 53.85 |
Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.